Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HTG Molecular Diagnostics Inc HTGMQ

Healthcare Medical Devices
HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and... see more

Recent & Breaking News (GREY:HTGMQ)

HTG Molecular Diagnostics Announces Distribution Agreements with Gamidor in Israel and Durviz in Spain and Portugal

GlobeNewswire April 11, 2016

HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2015 Results

GlobeNewswire March 24, 2016

HTG Molecular Diagnostics Announces IVD Development and Supply Agreement with Thermo Fisher Scientific

GlobeNewswire March 21, 2016

HTG Molecular Diagnostics to Hold 2015 Fourth Quarter and Full Year Financial Results Conference Call on March 24, 2016

GlobeNewswire March 15, 2016

CORRECTING and REPLACING – HTG Molecular Diagnostics Establishes Immuno-Oncology Scientific Advisory Board

Press Releases February 16, 2016

CORRECTING and REPLACING - HTG Molecular Diagnostics Establishes Immuno-Oncology Scientific Advisory Board

GlobeNewswire February 16, 2016

HTG Molecular Diagnostics Establishes Immuno-Oncology Scientific Advisory Board

Press Releases February 16, 2016

HTG Molecular Diagnostics to Present at the Leerink Partners 5th Annual Global Healthcare Conference

GlobeNewswire January 27, 2016

Investors Flock to Pressure BioSciences as Its Patented PCT Platform Goes Mainstream

Accesswire January 15, 2016

James (Jim) LaFrance Joins the Board of Directors of HTG Molecular Diagnostics

GlobeNewswire December 2, 2015

HTG Molecular Diagnostics Reports Third Quarter 2015 Results

GlobeNewswire November 12, 2015

HTG Molecular Diagnostics to Present at the Canaccord Genuity Medical Technologies and Diagnostics Forum

GlobeNewswire November 5, 2015

HTG Molecular Diagnostics to Hold 2015 Third Quarter Financial Results Conference Call on November 12, 2015

GlobeNewswire November 2, 2015

Lee R. McCracken Joins the Board of Directors of HTG Molecular Diagnostics

GlobeNewswire October 27, 2015

HTG Molecular Diagnostics Launches Next-Generation Sequencing-Based Cell of Origin Assay for Diffuse Large B-Cell Lymphomas

GlobeNewswire October 12, 2015

HTG Molecular Launches Next-Generation Sequencing-Based Immuno-Oncology Assay

GlobeNewswire October 1, 2015

PROOF Centre to Begin Clinical Validation of Heart Transplant Rejection Liquid Biopsy Test Using the HTG EdgeSeq System, a Next-Generation Sequencing (NGS)-Based Platform

GlobeNewswire September 21, 2015

Making LIFE Better: HTG Molecular Diagnostics Receives AZBio Fast Lane Honors

Business Wire September 18, 2015

HTG Molecular Diagnostics Reports Second Quarter 2015 Results

GlobeNewswire August 6, 2015

HTG Enters Worldwide Innovative Networking (WIN) Consortium for Personalized Cancer Medicine

GlobeNewswire August 5, 2015